edgarwiki

Impairment

431 staff comments in this corpus, to 247 registrants, across 14 of the 15 calendar quarters this corpus covers.

Coverage is partial and not continuous. This corpus holds CORRESP filings from 2023Q1–2026Q3 (83–100% of each quarter's EDGAR total). It holds nothing filed after 2026-07-17. If an issue page shows no comment from one of those periods, the reason is that edgarwiki has no data for it — not that the staff raised nothing. Counts on this site are counts within this corpus and are not SEC-wide totals. Every quotation is verbatim and links to its filing; what is incomplete is coverage, not accuracy. Per-quarter figures: Methodology.
MeasureValue
Comments raising this issue431
Share of all 92,899 comments in the corpus0.5%
Distinct registrants247
With a recorded company response430

When these comments were filed

By the quarter the CORRESP filing was filed. The third column is how much of that quarter's EDGAR CORRESP output this corpus holds — read it before comparing two rows. A quarter marked never ingested contributes no comments to this page for reasons that have nothing to do with the SEC.

QuarterComments here Corpus coverage of that quarter
2023Q14493%
2023Q24891%
2023Q35393%
2023Q45696%
2024Q13893%
2024Q25083%
2024Q33390%
2024Q44396%
2025Q11592%
2025Q22689%
2025Q31890%
2025Q4393%
2026Q1385%
2026Q21100%
2026Q30100%

The exchanges

Verbatim, most recent first. Quotations are exact spans from the filing linked beneath each one; long passages are truncated with an ellipsis and never altered.

SEC staff comment
24. We note your response to prior comment 49 in which you indicate that the AI segment has two reporting units. As mentioned in comment 1 above, we also note recent statements made by Mr. Musk and news reports about changes to the AI segment. To the extent that one of the reporting units within the AI segment includes assets associated with the former xAI business, please tell us how you considered the need to perform an interim goodwill impairment assessment for that U.S. Securities and Exchange Commission May 20, 2026 Page 11 reporting unit as of March 31, 2026. Your response should also tell us how you considered the need to perform impairment testing as of March 31, 2026 for any other long-lived assets and intangible assets associated with the former xAI business. Refer to ASC 350-20-35-30, 350-40-35-1, and 360-10-35-21.
The company responded
The Company acknowledges the Staff’s comment and notes that the AI segment has two reporting units: X reporting unit which is comprised of the former X business; and xAI reporting unit which is comprised of the former xAI business (excluding former X business). Substantially all of the goodwill attributable to the Company's AI segment is attributable to the X reporting unit. For the period ended March 31, 2026, the Company assessed if there are any events or circumstances that could more likely than not reduce the fair value of the X and xAI reporting units in the AI segment below its carrying amount. As clarified on pages 12, 16, 53, and 54 of the Registration Statement, although there could be certain risks with an acquisition and integration of an early stage company such as xAI, no triggering events have occurred during the three months ended March 31, 2026 that indicated the…
SPACE EXPLORATION TECHNOLOGIES CORP · filed 2026-05-20 · 0001628280-26-036964
SEC staff comment
1. You disclose, “there have been no material changes to the items disclosed as critical accounting policies and estimates,” including goodwill, since the disclosure in the Form 10-K. Please expand your disclosure to address the subsequent substantial decrease in market capitalization and the impact on your assessment of the likelihood of future material goodwill impairment charges. Tell us and disclose your consideration of ASC 350-20-35-30 and the need to perform a more recent impairment test.
The company responded
The Company acknowledges the Staff’s comment. We will enhance our future disclosures to address our consideration of the Company’s market capitalization, including any declines in market capitalization, if applicable, in our goodwill impairment assessment. We propose to include enhanced disclosure within the Critical Accounting Policies section of our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), beginning with our Form 10-Q for the Fiscal Quarter Ended March 31, 2026. The following is an illustration of the disclosure updates (underscored language indicates new disclosure) based on page 60 of our Form 10-Q filed on February 5, 2026. Critical Accounting Policies […] During the period since our May 1, 2025 annual impairment test through December 31, 2025, the Company experienced decreases in its market capitalization, as a result of…
COTY INC. · filed 2026-03-10 · 0001024305-26-000018
SEC staff comment
1. We note the disclosure in your financial statement footnotes that you performed a quantitative impairment analysis related to certain reporting units and a qualitative impairment analysis related to other reporting units and concluded no goodwill was impaired. Given the significance of your goodwill balance, please revise your Critical Accounting Estimates in future filings to clarify whether any of your reporting units are at risk of failing the goodwill impairment test. A reporting unit is at risk of failing the impairment test if it has a fair value that is not substantially in excess of carrying value. If no reporting units are at risk based on your most recent impairment test, please disclose such information to your readers as we believe it provides them with valuable information in assessing the sensitivity of your goodwill to future impairment. Alternatively, if a reporting…
The company responded
In future filings, to the extent applicable, we will include as part of our critical accounting estimate disclosures the fact that no reporting units are at risk of failing the impairment test as they have a fair value that is substantially in excess of carrying value. Our proposed revised wording for this critical accounting estimate is below (changes underlined for emphasis). Proposed wording in future Form 10-K filings: Goodwill and Other Long-Lived Assets Our Management annually reviews goodwill and other long-lived assets for impairment or whenever events or changes in circumstances indicate the carrying amount may not be recoverable. If we determine that the carrying value of the goodwill and other long-lived assets may not be recoverable, we record a permanent impairment charge for the amount by which the carrying value of the goodwill and other long-lived assets exceeds it fair…
ESCO TECHNOLOGIES INC · filed 2026-03-03 · 0001104659-26-022637
SEC staff comment
1. We note that you recorded material goodwill and intangible asset impairment charges in prior periods. We also note that the assessment of goodwill for impairment is identified by your auditor as a critical audit matter in their audit report. Based on the continued materiality of goodwill and intangible assets to your financial statements, underlying negative operating trends, and the fact that your net book value exceeds your market capitalization, please more fully explain to us how you determined the estimated fair values of your reporting units exceed their carrying values. In addition, to the extent you conclude an impairment charge that could materially impact your financial statements is reasonable possible, expand your disclosures to address the following: • Disclose whether you performed an impairment test since your most recent annual impairment test and explain why or why…
The company responded
As described in Critical Accounting Policies in the Company’s Form 10-K for the fiscal year ended December 31, 2024, the Company has identified Global Ceramic, Flooring North America (“Flooring NA”) and Flooring Rest of the World (“Flooring ROW”) as its reporting units for the purposes of allocating goodwill as well as assessing impairments. As of the Company’s 2024 annual goodwill impairment testing date, which was the first day of the fourth quarter of 2024 (the “2024 Annual Impairment Test Date”), the Company completed quantitative goodwill impairment tests (the “Annual Impairment Tests”) and determined that the estimated fair values of its reporting units with goodwill exceeded their carrying values and that the Company did not have any at-risk reporting units. Additionally, on an interim basis the Company assesses if a triggering event has occurred that might reduce the fair value…
MOHAWK INDUSTRIES INC · filed 2026-01-13 · 0001104659-26-003385
SEC staff comment
11. We note your disclosure that you evaluate goodwill for impairment annually at October 1 and whenever events or circumstances make it more likely than not that impairment may have occurred. In light of the significant amount of goodwill on your balance sheet, as well your operating losses for the periods presented, please tell us if you have completed your goodwill impairment analysis for 2025 and if so please provide us with the results of such analysis. U.S. Securities and Exchange Commission December 15, 2025 Page 8
The company responded
The Company advises the Staff that the goodwill impairment assessment as of October 1, 2025 is currently being completed by the Company. While the Company has experienced operating losses, the Company has analyzed macroeconomic conditions, industry and market conditions, cost factors, financial performance and other relevant entity-specific considerations and has preliminarily concluded that it is not more likely than not that the fair value is below carrying value as of October 1, 2025. In addition, there was significant margin between the most recent equity value as part of Company’s most recent valuation of incentive awards and the Company’s carrying value. Intellectual Property, page 129
Yellowstone Midco Holdings II, LLC · filed 2025-12-15 · 0001193125-25-318605
SEC staff comment
2. We note your disclosure in Item 3 on page 96 of the patent infringement complaints filed against you by Teva Pharmaceutical Industries Ltd. on August 13, 2024 and September 20, 2024 with the European Patent Office. We also note that you did not include disclosure of your estimate of potential exposure to loss contingencies in Note 8, Commitments and Contingencies, on page F-24. Please tell us how you applied ASC 450-20-25 in assessing the likelihood of the loss or impairment of an asset or the incurrence of a liability as a result of the litigation, and your consideration of providing the disclosures required by ASC 450-20-50-3 through 50-5 as it relates to this potential loss contingency, including the amount or range of reasonably possible losses in excess of recorded amounts. [***] Certain confidential information contained in this document, marked by bracketed asterisks, has been…
The company responded
The Company respectfully acknowledges the Staff’s comment and advises the Staff that it evaluates the status of all of its legal proceedings in each reporting period, including the patent infringement complaint filed against the Company by Teva Pharmaceutical Industries (“Teva Complaint”), to assess whether accruals are appropriate under ASC 450-20-25-2 and to determine whether an estimate of possible loss or a range of possible losses can be made under ASC 450-20-50. During this evaluation, the Company’s management considers all existing and new matters, including, but not limited to, (i) the nature and status of each matter; (ii) the advice of legal counsel and other advisors related to each matter; (iii) the Company’s experience or that of other entities in similar matters; (iv) the Company’s belief in whether it has meritorious and valid substantive defenses against the allegations…
Arcutis Biotherapeutics, Inc. · filed 2025-10-10 · 0001193125-25-236762
SEC staff comment
5. Please more fully address the following items. ● You state idle assets are accounted for in accordance with IAS 16. Tell us, and revise future filings to clarify, if idle assets are being depreciated and, if not, explain to us how you considered the guidance in paragraph 55 of IAS 16. ● You state you engaged an appraiser to determine the fair value of Republic Steel’s assets for the purposes of assessing potential impairment under IAS 36 and that no impairment was identified in 2024. Based the lack of cash flows related to the assets, tell us, and revise future filings to clarify, how estimated fair value was determined, including the amount or percentage by which estimated fair value exceeds carrying value. ● You state “As of December 31, 2024, a portion of Republic Steel’s inventory consisted of steel products that, if sold at current market prices, would generate a loss;…
The company responded
Idle assets are being depreciated in accordance with paragraph 55 of IAS 16, the Company continues to depreciate these idle assets because management has not yet determined that they are to be permanently withdrawn from use. Accordingly, the assets are depreciated over their remaining useful lives despite being inactive. The Company intends to maintain this accounting treatment in future filings unless management’s plans regarding these assets change. The table below presents a comparative summary of the carrying values and appraised fair values of the Company’s property, plant and equipment as of December 31, 2023 and 2024. All figures are in thousands of U.S. dollars and are based on values determined by an independent appraiser: Year Carrying Value Fair Value; Land & Buildings Fair Value; Machinery & Equipment Total Fair Value Excess Fair Value % Excess over Carrying Value 2023 $…
GRUPO SIMEC, S.A.B. de C.V. · filed 2025-10-01 · 0001213900-25-094936
SEC staff comment
3. If material, please expand your disclosure to address any intangible assets corresponding to your operations in countries for which you have recorded a full deferred tax asset valuation allowance. Based on the existing disclosure, it is not clear whether such intangible assets are material or whether the associated recoverability estimates are impacted by known adverse facts and circumstances . The Company acknowledges the Staff’s comment and respectfully advises the Staff that the Company has intangible assets residing in two countries that have full deferred tax asset valuation allowances. These two countries are [***] and [***] with net intangible assets in the amount of [***] and [***], respectively. The Company determined that the intangible assets residing in [***] are immaterial to the Company’s consolidated financial statements. In respect to the deferred tax assets residing…
The company responded
In response to the Staff comments, going forward, the Company will evaluate the materiality of its intangible assets corresponding to the Company’s operations in countries for which we have recorded a full deferred tax asset valuation allowance, as applicable, and, based on the facts and circumstances, include in future filings where we have concluded that such presentation is material, including if applicable in the critical accounting estimates section in its next Form 10-K for the fiscal year ended December 31, 2025. Major Customers, page 56 4. It is not clear whether the revenues corresponding to any individual countries in your South and Central America category should be separately disclosed pursuant to ASC 280-10-50-41. Please tell us the three countries that primarily comprise the December 31, 2024 South and Central America revenue amount and quantify each country's revenue.…
AMERICAN VANGUARD CORP · filed 2025-09-25 · 0001193125-25-218050
SEC staff comment
8. Goodwill and Other Intangible Assets, Net, page F-31 We note that you performed a quantitative goodwill impairment test as of December 31, 2024, which indicated that the fair value of each reporting unit exceeded its carrying amount. We also note that the decline in Search Advertising revenues starting from the second quarter of 2024 through the second quarter of 2025 has been material. Considering the significant and sustained decline in Search Advertising revenues, please provide information for investors to assess the probability of future goodwill impairment charges. For example, please disclose whether the reporting unit is at risk of failing step one of the quantitative impairment test or that the fair value of your reporting unit is substantially in excess of carrying value and is not at risk of failing step one. If the fair value of your reporting unit is not substantially in…
The company responded
The Company respectfully acknowledges the Staff’s comment. The Company advises the Staff that it performed its annual goodwill impairment assessment for the Search Advertising reporting unit in the fourth quarter of 2024, and the fair value of the reporting unit exceeded its carrying value by 22.3%, which the Company believes to be substantially in excess of its carrying value. As such, the Company does not believe its Search Advertising reporting unit is at risk of failing step 1 of the quantitative impairment test. In future 20-F filings, the Company will include disclosure as to whether the reporting unit is at risk of failing step 1. Based on the above factors, the Company believes Search Advertising’s fair value is substantially in excess of its carrying value. In the future, however, if the Company believes that the reporting unit is at risk of a goodwill impairment charge, it…
Perion Network Ltd. · filed 2025-09-11 · 0001178913-25-003297
SEC staff comment
5. Your revised disclosures in response to prior comment 9 indicate that management evaluated macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, and various entity specific events to determine that an impairment indicator was not present and an additional quantitative impairment test was not required. Please provide us with your qualitative assessment so that we may better understand how you determined that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount including goodwill.
The company responded
We acknowledge the Staff’s comment. In response, and in light of both the Staff’s observations and events occurring in the updated reporting period, the Company performed a quantitative goodwill impairment analysis in addition to its prior qualitative assessment. The results of this quantitative evaluation, together with the related disclosures, have been included in the Amended Registration Statement. Please see pages 244-245 of the Amended Registration Statement for the revised disclosure. SharonAI Consolidated Financial Statements Consolidated Statements of Changes in Stockholders’ Equity, page F-88
Roth CH Holdings, Inc. · filed 2025-09-10 · 0001829126-25-007295
SEC staff comment
1. Please present charges related to goodwill impairment in a separate line item in accordance with ASC 350-20-45-2.
The company responded
In response to the Staff’s comment, in future filings, the Company will classify any future goodwill impairment charges, if material, within a separate financial statement line item on its consolidated statements of income in accordance with the guidance in ASC 350-20-45-2. The Company respectfully submits that the requested presentation would not materially change a user’s understanding of the Company’s results of operations for the year ended December 31, 2024, as it believes the nature and amount of the impairment charges are adequately disclosed on page F-44 in Note 9 to the Company’s Consolidated Financial Statements and page 82 in Management’s Discussion and Analysis of Financial Condition and Results of Operations. Note 3. Revenue from Contracts with Customers, page F-27
Hyatt Hotels Corp · filed 2025-09-04 · 0001104659-25-087473
SEC staff comment
59. Please tell us and revise future filings to clarify the following items. ● Explain your current intentions regarding Republic Steel and its remaining assets. ● Explain how you are accounting for Republic Steel’s assets since you ceased operations. Refer to IFRS 5 and IAS 16. ● In the third paragraph on page 59, you quantify assets related to the Lorain, Ohio facility for the years 2022, 2021 and 2020. Quantify amounts related to the current periods presented. ● In the fourth paragraph on page 59, we note you “performed an analysis of the fair value of the four facilities (Canton, Solon, Massillon and Lackawanna) and determined net book value exceeded fair value by approximately U.S. $130.7 million (Ps. 2,701 million) and as such recognized an asset impairment of this amount during the year ended December 31, 2015”. This disclosure appears to relate to the Lorain facility impairment…
The company responded
The Company takes note of the Staff’s comment and provides the following explanations, which will also be reflected in expanded disclosures in future Form 20-F filings. Current intentions regarding Republic Steel. At present, management has determined that the Republic Steel facilities will remain inactive unless there are changes in prevailing economic conditions that justify resuming operations. Accounting treatment of Republic Steel assets. As of December 31, 2024, because management does not intend to sell the facilities, IFRS 5 (Non-current Assets Held for Sale and Discontinued Operations) does not apply. Instead, the assets continue to be accounted for in accordance with IAS 16 (Property, Plant and Equipment), measured at cost less accumulated depreciation and impairment, as appropriate. In addition, the Company engaged an authorized appraiser to determine the fair value of the…
GRUPO SIMEC, S.A.B. de C.V. · filed 2025-09-03 · 0001213900-25-084141
SEC staff comment
3. We see that you have included a draft audit opinion along with your draft amendment, which appears to be incomplete not only with respect to the date of issuance, but also the explanatory language regarding the restatement, and communication of critical audit matters pertaining to the evaluation of capitalized oil and gas property costs for impairment under the full cost method, based on the requirements of PCAOB AS 3101, paragraphs 18(e) and 11 through 14. Please discuss these requirements with your auditors and confirm that such content will appear in the opinion that accompanies the amendment. However, if this is not their intention, provide us with an explanation from the firm detailing how the aforementioned guidance was considered in formulating their view.
The company responded
In response to the Staff’s comment, the Company respectfully advises the Staff that in light of the auditing review still in progress as of the date of the response letter submitted May 9, 2025, the Company’s independent auditors were not in a position to issue its revised opinion. The Company’s prior submission of the draft Annual Report on Form 10-K remained subject to completion of the audit. The new auditor report is included in the Draft Amendment beginning on page F-1. Note 2 – Going Concern, page F-6
Next Bridge Hydrocarbons, Inc. · filed 2025-08-18 · 0001199835-25-000277
SEC staff comment
5. Please address the apparent inconsistency between your disclosure in the second paragraph on page F-8, stating that you recorded an impairment of $28,192,277 related to properties other than the Orogrande Project in 2022, with details in the corresponding financial statements, which do not identify this change.
The company responded
In response to the Staff’s comment, the Company has revised the disclosures, and directs the Staff to the updated disclosures in Note 5 of the Draft Amendment. Note 12 – Correction of Previously Issued 2023 Financial Statements, page F-19
Next Bridge Hydrocarbons, Inc. · filed 2025-08-18 · 0001199835-25-000277
SEC staff comment
7. Please expand your disclosure to include a description of the errors that have led to the restatement to comply with ASC 250-10-50-7, including the errors in your initial accounting in the 2022 annual report, and the errors attendant to the restatements that were made to the 2022 annual amounts when filing your 2023 annual report, and to the 2023 first, second and third quarter interim amounts, in the comparative presentations when filing the corresponding interim reports. For example, it should be clear that your initial accounting for the oil and gas properties was incorrectly based on a presumption of fair value and did not properly consider the continuity of the economic interests that had been conveyed via preferred shares issued by Torchlight Energy Resources, Inc. to its common shareholders just prior to its reverse merger with Meta Materials Inc., and with regard to your…
The company responded
In response to the Staff’s comment, the Company has revised the relevant disclosures as reflected in the Draft Amendment.
Next Bridge Hydrocarbons, Inc. · filed 2025-08-18 · 0001199835-25-000277
SEC staff comment
10. We note that you provided a notice of late filing for your 2024 annual report on March 31, 2025, which includes a brief description of the pending restatement that indicates it pertains to a prior restatement “related to the timing of impairment adjustments” that were previously recorded in 2022 but will be recorded in 2024 instead. You further state that the adjustment for 2024 will approximate $73 million and that such impairment “had been previously addressed in prior year filings.” However, the reasons cited in your correspondence during our review for your mid-2024 restatement of the 2022 annual amounts and the 2023 interim amounts reflected an incorrect application of the full cost method of accounting for oil and gas activities, and did not encompass the October 8, 2024 decision by University Lands to not extend your Development Unit Agreement for the Orogrande asset, nor its…
The company responded
In response to the Staff’s comment, the Company respectfully advises the Staff that the relevant disclosures pertaining to the impairment charge will conform to the Staff’s guidance in the 2024 Annual Report on Form 10-K when filed. Note 14 – Explanation of Quarterly Impact, page F-26
Next Bridge Hydrocarbons, Inc. · filed 2025-08-18 · 0001199835-25-000277
SEC staff comment
9. Please tell us whether you performed interim and annual impairment tests for goodwill and intangible assets and if so, revise your disclosures to include critical accounting policies that discuss the results of the impairment analyses. Also, given the materiality of your goodwill balance and to provide investors with useful and meaningful information necessary to understand how you determined whether an impairment charge is necessary as well as the probability of future goodwill impairment, please revise to provide the following disclosures: ● the date that you perform your annual goodwill impairment test each year; ● a discussion of how goodwill and intangible assets are tested, including whether you performed a qualitative and/or quantitative test; ● the specific factors and critical assumptions used to estimate the fair value of the reporting unit(s) and the degree of uncertainty…
The company responded
We acknowledge the Staff’s comment and have revised the disclosures accordingly, see pages 223 of the Amended Registration Statement. Goodwill is tested for impairment at least annually, at the beginning of the fourth fiscal quarter, or more frequently if events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Finite- lived intangible assets are assessed for impairment under ASC 360-10 if events suggest their carrying amount may not be recoverable. The Company did not identify any impairment indicators and thus did not perform an impairment analysis on the intangible assets. The Company performs its goodwill impairment assessment in accordance with the guidance in ASC 350, Intangibles—Goodwill and Other, using both qualitative and quantitative factors. In accordance with the standard,…
Roth CH Holdings, Inc. · filed 2025-08-12 · 0001829126-25-006121
SEC staff comment
1. We note your use of Adjusted EBITDA, which represents EBITDA adjusted for changes in the fair value of inventory, share-based payment expense, impairment losses (and gains) on financial assets, and other expenses (or income). Please quantify the components of the adjustment for “other expenses, net” and explain your consideration of Item 10(e) of Regulation S-K in excluding these amounts from your Non-IFRS measure. In this regard, based on your reconciliation on page 74, “other expenses, net” appears to represent the most significant adjustment in arriving at Adjusted EBITDA.
The company responded
In response to the Staff’s comment, we respectfully advise that we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors evaluates our results. As defined in our filings, Adjusted EBITDA means net income (loss) before interest, taxes, depreciation and amortization, adjusted for changes in the fair value of inventory, share-based payment expense, impairment losses (and gains) on financial assets, and other expenses (or income). We believe the adjustments reflect non-recurring or non-cash items that our management, board of directors and others believe are appropriate to provide an additional measure of our underlying earnings performance. The components of the adjustment for “Other expenses, net” are as follows, which we believe reflects appropriate…
Intercure Ltd. · filed 2025-08-07 · 0001641172-25-022533
SEC staff comment
2. We added back NIS 42 million and NIS 28 million (for 2024 and 2023, respectively) of damage compensation related to the “Iron Swords” war between Hamas and Israel (the “War”) from the Israel Tax Authority, which was included in the “Other expenses, net” caption, as it reflects compensation for loss of profit (i.e., the equivalent earning in prior periods which were earned during the regular course of business were presented in EBITDA and Adjusted EBITDA and accordingly we believe it is appropriate that the compensation for loss of profit should be included in the EBITDA and Adjusted EBITDA, to help facilitate the comparison between the periods). 3. We added back inventory impairment, which was recorded for the first time since our inception and resulted from a decline in inventory value, mainly due to the impact on our product portfolio following the War, which affected the sales of…
The company responded
In response to the Staff’s comment, we respectfully advise that we had presented a list of branded pharmaceutical-grade products to demonstrate the scope and range of our business offerings. While we recognize that disaggregated revenue may provide relevant information in some situations, we have determined that such disclosure would not provide relevant information or be required or material for readers of our Annual Report or potential investors. Although our revenue stream is comprised of over 100 distinct pharmaceutical-grade products under various brand names, we have determined that as a result of the similarity of the contract terms and characteristics, profitability profile, working capital requirements and product life cycle of the product lines within our revenue stream, subject to immaterial differences, presenting a more detailed revenue breakdown would not provide a more…
Intercure Ltd. · filed 2025-08-07 · 0001641172-25-022533
SEC staff comment
2. We note that your equity method investments comprise over 16% of your total assets. Please explain to us why your equity in Income from equity method investments balance on page F-7 has decreased substantially even though your disclosure on page F-33 reports increases in the revenues and income of these investees. Please also clarify for us whether you have received any dividends from these investees. For each of the equity investees referenced in footnotes (a) and (b), please describe in detail the objective evidence you considered in concluding that no impairment charges were required in 2024. The Staff’s comment is duly noted. (1)
The company responded
In response to the Staff’s comment, the Company respectfully submits that, while there was an increase in combined revenue and net income of all the equity method investments of the Group as disclosed on page F-33 of the 2024 Form 20-F, the “income 2 Yatsen Holding Limited July 25, 2025 Page 3 from equity method investments, net” presented on the face of consolidated statements of operations decreased substantially in 2024 as compared with 2023. This is primarily because the Group’s income from equity method investments reflects an aggregated net effect of the corresponding profits and losses of each investee and the Group’s respective share of ownership percentages in each investee. In contrast, the combined net income disclosed on page F-33 of the 2024 Form 20-F represents the gross net income or loss of all equity method investments at the investees standalone entity-level, without…
Yatsen Holding Ltd · filed 2025-07-25 · 0000950170-25-098557
SEC staff comment
1. We have read your response to prior comment one. We note you plan to disclose the range of calculated fair values over book values for your indefinite-lived intangible assets and identify and disclose brands you consider at higher risk of impairment. For brands you consider to be at higher risk of impairment, please confirm you will also disclose and discuss the key assumptions used to estimate their fair values and the potential events or circumstances that could reasonable be expected to negatively those key assumptions.
The company responded
We confirm that in future filings for brands that we consider to be at higher risk of impairment, we will also disclose and discuss the key assumptions used to estimate their fair values and the potential events or circumstances that could reasonably be expected to negatively impact those key assumptions. Quality Foods Since 1889 Securities and Exchange Commission July 23, 2025 Page 2
B&G Foods, Inc. · filed 2025-07-23 · 0001104659-25-070085
SEC staff comment
2. We have read your response to prior comment five. Given the materiality of goodwill and intangible assets to your total assets and equity and your disclosure that sales strategies and promotional marketing spending are centered on individual brands, we continue to believe that disclosing net sales by material brand is meaningful and useful. We note your disclosures on page 38 of the book values of indefinite-lived trademarks for each brand whose net sales equaled or exceeded 3% of fiscal 2024 and fiscal 2023 net sales and for “all other brands” in aggregate; however, without also disclosing net sales by material brand, it is not clear to us how an investor would be able to assess the potential exposure and impairment risk related to these assets. Please provide such disclosures in MD&A in future filings.
The company responded
We agree with the Staff’s suggestion that disclosing net sales by brand would enhance the meaningfulness of our current practice of reporting in MD&A the book values of indefinite-lived trademarks for each brand whose net sales equaled or exceeded 3% of our net sales. Accordingly, we plan to include in MD&A in future filings disclosures of net sales by brand for each brand whose net sales equaled or exceeded 3% of our net sales. These disclosures will be similar to the individual brand net sales disclosures that had previously appeared in our financial statement footnotes prior to our transition to four reportable segments. Consolidated Financial Statements (3) Acquisitions and Divestitures Divestiture of Green Giant U.S. Shelf-Stable Product Line, page 69
B&G Foods, Inc. · filed 2025-07-23 · 0001104659-25-070085
SEC staff comment
3 . We have read your response to prior comment two. Please address the following: · Revise future filings to clarify how trademarks were allocated to assets held for sale; and Response : We confirm that we will revise future filings to clarify how trademarks were allocated to assets held for sale. · You state immediately prior to the sale, the realizable value of inventory exceeded the cost, as the inventory remained saleable in the ordinary course of business; however, after the broader group of assets was characterized as assets held for sale, the inventory lost its individual character and its impairment was recorded as part of an impairment of the group of assets held for sale. More fully explain to us what "the inventory lost its individual character" means and address why the inventory would not remain saleable at realizable value after the transfer to assets held for sale. Also,…
The company responded
In connection with the sale of the Green Giant U.S. shelf-stable product line, our company classified the related assets as held for sale in accordance with ASC 360-10-45-9. Consistent with the prescribed ordering of impairment testing for assets held for sale, we first evaluated assets outside the scope of ASC 360, including inventory under ASC 330, and concluded that no impairment was required under ASC 330, as the realizable value of the inventory exceeded its carrying amount. Upon this classification, we evaluated the disposal group as a single unit of account for impairment purposes, consistent with the guidance in ASC 360-10-35-38 through 35-43. As a result, we determined that the individual assets within the disposal group, including inventory, no longer represent separate units of account for measurement purposes. The disposal group was assessed as a whole, and the impairment…
B&G Foods, Inc. · filed 2025-07-23 · 0001104659-25-070085
SEC staff comment
2. In light of the total shareholders’ deficit balances of your other subsidiaries, VIEs and VIEs’ subsidiaries, it is unclear why Yimutian Inc. is reporting a long-term investments balance of RMB 507,962. Please clarify and advise us. Also, revise the description of the long-term investments line-item to more clearly describe its nature. In this regard, identifying your interest in the VIEs as an investment may be confusing since you do not own the equity of the VIEs. The Staff’s comment is duly noted. The Company respectfully advises the Staff that deficits in other subsidiaries and in VIEs and VIEs’ subsidiaries do not directly reduce the accounting carrying amount of the holding company’s specific profitable or fairly valued investment asset unless there is concrete evidence linking those deficits to an impairment of that specific asset. The Company further submits to the Staff…
The company responded
In response to the Staff’s comment, the Company has revised the disclosure on the page F-34 of the Registration Statement. Regarding the key assumptions used to estimate the fair value of options granted in 2024, the Company respectfully advises the Staff that, as it did not grant new stock options in 2024, it maintained the assumptions established in the 2023 assessment. U.S. Securities and Exchange Commission July 22, 2025 Page 5 As of December 31, 2023 As of December 31, 2024 Before Adjustment Balance with Other Group Entities Elimination of Intercompany Amounts After Adjustment Before Adjustment Balance with Other Group Entities Elimination of Intercompany Amounts After Adjustment (in thousands) ASSETS Current assets Cash 496 — — 496 129 — — 129 Restricted cash — — — — — — — — Accounts receivable, net — — — — — — — — Amounts due from related parties 3,386 — — 3,386 3,436 — — 3,436…
Yimutian Inc. · filed 2025-07-22 · 0001213900-25-066616
SEC staff comment
Comment : We note your response to prior comment 33 and revised critical accounting estimates disclosures regarding goodwill impairment testing. Please further revise and expand your disclosure for the following: • the percentage by which fair value exceeded carrying value as of the date of the most recent test; • a description of the key assumptions used and how the key assumptions were determined as described in your response; and • how much each estimate and/or assumption has changed over a relevant period, and the sensitivity of the reported amount to the methods, assumptions and estimates underlying its calculation.
The company responded
The Company advises the Staff that Mount Logan has revised the disclosure beginning on pages 305 and 339 of the Registration Statement in response to the Staff’s comment. 3 Management's Discussion and Analysis, page 340 8. Comment : We note that you have included interest rate sensitivity disclosure for Mount Logan on pages 270 and
Yukon New Parent, Inc. · filed 2025-07-03 · 0002051820-25-000056
SEC staff comment
2. Please provide a more detailed analysis supporting your conclusion that a full impairment of the remaining $10 million in goodwill is not necessary when impairment became probable. Specifically, explain to us the last sentence of your response that as the Penguin Edge business continues to wind down, cash flows from the business will be received by the Company, decreasing the remaining cash flows from customer contracts and resulting in further declines in the fair value of the business and Sidley Austin (DC) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships. Page 2 additional impairments of goodwill. In this regard, we would expect that the remaining cash flows have already been considered in the fair value calculation at the time of measurement. Please advise. Additionally, in your…
The company responded
We respectfully acknowledge the Staff’s comment. As previously disclosed in the Company’s periodic reports, in the second fiscal quarter of 2023, the Company initiated a plan to wind down manufacturing and discontinue the sale of legacy products offered through its Penguin Edge business. As of February 28, 2025, the Company determined that it was more likely than not that the fair value of the Penguin Edge business was less than its carrying amount and elected to bypass the qualitative assessment as allowed under ASC 350-20-35-70. Following the guidance in ASC 350-20-35-4 through 35-8 to perform the quantitative goodwill impairment test, the Company determined that as of February 28, 2025, the fair value of the Penguin Edge business of $20.3M was lower than its carrying amount of $26.4M, resulting in a goodwill impairment charge of $6.1M. While the Penguin Edge business’s goodwill will…
Penguin Solutions, Inc. · filed 2025-06-27 · 0001193125-25-151564
SEC staff comment
1. In your future filings, please revise the roll-forward on page F-24 to present the amount of impairment charges for in-process research and development, such as the $2.0 million impairment recorded during 2024. Company
The company responded
The Company respectfully acknowledges the Staff’s comment regarding the presentation of impairment charges related to in-process research and development in the roll-forward schedule on page F-24. In future filings, the Company will revise the schedule to separately disclose these impairment charges for improved transparency and to align with the presentation of our intangible asset roll-forward, which includes this level of detail in the same table.
KIORA PHARMACEUTICALS INC · filed 2025-06-20 · 0001372514-25-000057
SEC staff comment
2. Your response to prior comment 1 indicated that you now anticipate the wind down of certain aspects of the Penguin Edge reporting unit to be completed by approximately the end of 2025, and that the future impairment of the goodwill balance is probable. Please tell us the following: • whether you anticipate the full impairment of the remaining $10 million goodwill balance in the foreseeable future. Explain your basis if you do not believe it should be fully impaired even after you complete the wind down of Penguin Edge business. • how the probable impairment assumption factored into your current analysis that the fair value equals the carrying value at March 31, 2025. • the methods and key assumptions you used to estimate the fair value of the Penguin Edge business in connection with your goodwill impairment assessment during the second quarter of 2025. See guidance in ASC 350-10-50-2.
The company responded
We respectfully acknowledge the Staff’s comment. The Company anticipates that the remaining $10 million goodwill balance will be fully impaired upon the completion of the wind-down of the Penguin Edge business. Based on the Company’s current wind-down plan, the business is expected to materially cease operations by the end of calendar 2025. Page 5 After determining that conditions existed suggesting that it was more likely than not that the fair value of the Penguin Edge reporting unit may be less than its carrying amount, the Company utilized a discounted cash flow model to assess the fair value of the Penguin Edge business and reporting unit for the purpose of goodwill impairment during the second quarter of fiscal 2025. The Penguin Edge technology is becoming obsolete and is only sold to a small number of customers who we expect to phase out the technology. Therefore, for purposes of…
Penguin Solutions, Inc. · filed 2025-06-18 · 0001193125-25-142901
SEC staff comment
9. Your footnote disclosure on page F-32 indicates the Interconnect Solutions reporting unit was tested for impairment using the quantitative approach, and your disclosure in your Critical Accounting Estimates section indicates that for that reporting unit, the results indicated that the estimated fair values of the reporting units exceeded their respective carrying values. Please revise your disclosure to discuss whether the reporting unit is at risk of failing the quantitative impairment test or that the fair value of the reporting unit is substantially in excess of carrying value and are not at risk of failing. Additionally, we note that you used both cash flow model and market approaches in determining the fair value of your reporting units and you apply a weighting to the approaches to determine fair value. Please revise your disclosures to include the relative weighting used for…
The company responded
The Company respectfully acknowledges the Staff’s comment and advises the Staff that as of October 1, 2024 (the date of the Company’s annual goodwill assessment) and March 1, 2025 (the date of the Company’s most recent goodwill assessment) the Interconnect Solutions reporting unit’s fair value substantially exceeds the carrying value and thus is not at risk of failing the quantitative impairment test. The Company respectfully advises the Staff that it has revised its disclosures on page 94 of Amendment No. 1 to state that the Discounted Cash Flow Method and Guideline Public Company Method were equally weighted, and to address the Company’s approach for determining why such weighting was appropriate for determining fair value. Office of Manufacturing Division of Corporation Finance Securities and Exchange Commission June 18, 2025 Page 5 Our Customers, page 92
Qnity Electronics, Inc. · filed 2025-06-18 · 0001193125-25-142419
SEC staff comment
2. We note that none of your reporting units were impaired as of February 2, 2025 based on your annual goodwill impairment test. Please expand your disclosure in future filings to disclose whether any of your reporting units are at risk of failing the quantitative impairment test or that the fair value of each of your reporting units are substantially in excess of carrying value and are not at risk of failing. To the extent any reporting unit fair values are not substantially in excess of fair values, disclose the identity of those reporting units and the amount or percentage by which the fair value exceeds their carrying values. Refer to ASC 350-20-50 and Item 303(b)(3) of Regulation S-K.
The company responded
We acknowledge the Staff’s comment and, in future 10-K filings, will expand our disclosure to disclose whether any of our reporting units are at risk of failing the annual quantitative impairment test or that the fair value of each of our reporting units are substantially in excess of carrying value and are not at risk of failing. In addition, to the extent any reporting unit fair values are not substantially in excess of fair values, in future 10-K filings, we will disclose the identity of those reporting units and the amount or percentage by which the fair value exceeds their carrying value. 2 Notes to Consolidated Financial Statements Note 18 - Segment Information, page F-30
HOOKER FURNISHINGS Corp · filed 2025-06-17 · 0001185185-25-000659
SEC staff comment
1. Please enhance your disclosure in future filings to provide investors with the necessary information to assess the likelihood of future goodwill impairment charges. Specifically, address the following points: • Clearly identify the methods used to quantitatively assess goodwill for impairment and disclose the key assumptions used to estimate fair values, including how these key assumptions were determined. • If there are any changes to the methods or assumptions used to analyze goodwill for impairment, please identify the changes and explain the reasons behind them. For instance, we note that your footnote disclosure indicates the assessment performed in the first quarter of 2024 used both the market capitalization approach and a iRobot.com iRobot Corporation | 8 Crosby Drive, Bedford MA 01730 | 781.430.3000 discounted cash flow analysis, whereas the analysis performed in October…
The company responded
The Company acknowledges the Staff’s comment and advises the Staff that the Company will enhance its disclosure in its future filings with the Commission as described in the Staff’s comment. * * * * iRobot.com iRobot Corporation | 8 Crosby Drive, Bedford MA 01730 | 781.430.3000 If you have any questions with regard to the Company’s response or would like to discuss any of the matters covered in this letter, please contact the undersigned at (781) 430-3000. Sincerely, /s/ Karian Wong Karian Wong Executive Vice President and Chief Financial Officer iRobot.com iRobot Corporation | 8 Crosby Drive, Bedford MA 01730 | 781.430.3000
IROBOT CORP · filed 2025-06-16 · 0001159167-25-000064
SEC staff comment
2. We note you have sustained goodwill impairment charges in fiscal year 2024. In addition, we note that your auditor has included Goodwill Impairment Assessment as a critical audit matter in their audit opinion. We further note significant continuing impairment indicators such as the carrying value of your net assets substantially exceeding your market capitalization at December 28, 2024. Please expand your critical accounting estimates disclosure to include a discussion of your estimates and assumptions pertaining to goodwill, beyond your disclosures included in Note 11 on page 83. Your disclosures should identify the number of reporting units where goodwill is allocated and tested for impairment. Additionally, indicate whether the fair value substantially exceeds book value for all reporting units at the date of your most recent test. If the fair value of any reporting unit does not…
The company responded
We acknowledge the Staff’s comment requesting that we expand our critical accounting estimates disclosure in relation to the valuation methods and assumptions used in assessing goodwill for impairment, including the identification and allocation of goodwill to reporting units. In our Q2 Form 10-Q and, to the extent applicable, in future Form 10-K filings, we will expand the discussion of this critical accounting estimate to include (i) the number of reporting units where goodwill is allocated and tested for impairment, (ii) whether the fair value substantially exceeds carrying value for all reporting units at the date of our most recent test, and (iii) an United States Securities and Exchange Commission Division of Corporation Finance June 12, 2025 Page 8 expanded description of the estimates and assumptions relied upon in calculating fair value, including the reconciliation we perform…
INTEL CORP · filed 2025-06-12 · 0000050863-25-000091
SEC staff comment
2. Please expand your results of operations discussion to fully explain the negative factors that caused the impairment of goodwill expense recorded for both periods presented. In this regard we note that these impairments had an approximate 50% impact on your net loss in both periods. Please also expand your disclosure to explain the 33% impact on 2024 net loss caused by the warrant liability fair value adjustments.
The company responded
Please be advised that we have amended the disclosure on page 43 of the Amendment No. 1 per the Staff’s comment as follows: Impairment of goodwill Goodwill impairment expenses were $1,159,172 for the three months ended December 31, 2024 compared to $2,250,553 for the comparable period in 2023. For the fiscal years ended December 31, 2024 and 2023, we recognized a $3.4 million and $2.3 million goodwill impairment charge, respectively, which was primarily driven by a duplicate of the unexpected loss of a major customer and a subsequent reassessment of the financial outlook for our Meixin reporting unit. Specifically, during 2024, the Meixin unit experienced the early termination of a significant contract with a key customer, which materially reduced projected future cash flows. In conjunction with continued challenges in customer acquisition, the Company performed an interim impairment…
NOCERA, INC. · filed 2025-06-05 · 0001683168-25-004244
SEC staff comment
1. We note your disclosure that in light of the impairment of the Fiber segment goodwill of approximately $5 billion, the Company conducted a review during the fourth quarter of 2024, including analysis of both market-level and segment-level information, and determined there was no impairment of its Fiber segment long-lived assets. In performing your impairment testing, please tell us how you considered the guidance in ASC 350-20-35-31 in performing your recoverability test for your long-lived assets prior to your goodwill impairment test and how that may have impacted such analysis, if any. Company
The company responded
The Company acknowledges the Staff's comment and confirms that, in accordance with ASC 350-20-35-31, the Company had performed the impairment analysis of its Fiber segment long-lived assets prior to performing the goodwill impairment analysis and concluded there was no impairment of long-lived assets identified. This assessment had no impact on the goodwill impairment analysis or the amount of loss recorded for goodwill impairment in the fourth quarter of 2024. The Company advises the Staff that its Fiber segment represents both: a) an asset group for purposes of evaluating long-lived assets, as the lowest level for which identifiable discrete cash flows (including projected cash flows) are largely independent of the cash flows of other groups of assets is the overall Fiber segment level; and b) a reporting unit for purposes of evaluating goodwill. With respect to long-lived assets, in…
CROWN CASTLE INC. · filed 2025-06-04 · 0001051470-25-000154
SEC staff comment
2. We note your disclosure that you recorded losses for impairment on real estate assets in 2024 and 2022. Please tell us and revise future filings to disclose the segment in which the impaired long-lived asset (asset group) is reported. Refer to ASC 360-10- 50-2(d).
The company responded
Our recorded losses for impairment on real estate assets in 2024 and 2022 are related to the following segments: Building Reportable Segment 2024 2023 2022 One Lincoln Park Dallas $ 932 $ — $ — 750 West John Carpenter Freeway Dallas 17,500 — — 80 and 90 Central Street Boston 10,000 — — 161 Corporate Center Dallas 5,400 — — 9320 Excelsior Boulevard Minneapolis — — 10,000 Total impairment charge on real estate assets $ 33,832 $ — $ 10,000 We will include in future filings, beginning with our quarterly report on Form 10-Q for the quarter ending June 30, 2025, disclosure of the reportable segment in which the impaired long-lived asset is reported in accordance with ASC 360-10-50-2(d). May 28, 2025 Page 2 Sincerely, /s/ Laura P. Moon Laura P. Moon Chief Accounting Officer Piedmont Office Realty Trust, Inc. CC: Mr. C. Brent Smith, President, Principal Executive Officer and Director Ms. Sherry…
Piedmont Office Realty Trust, Inc. · filed 2025-06-02 · 0001042776-25-000125
SEC staff comment
5. You disclose that when you classify a disposal group as held for sale, you first test "all assets other than goodwill," then goodwill, and then the disposal group in its entirety. Please tell us how your impairment testing order complies with ASC 360-10-35-39. In particular, clarify if you test long-lived assets for impairment before or after goodwill.
The company responded
The Company respectfully acknowledges the Staff’s comment. Consistent with ASC 360-10-35-39, assets outside of the scope of ASC 360-10 were first tested for impairment, followed by goodwill in accordance with ASC 350-20, and then the disposal group in its entirety. To clarify, the Company does not test the reporting unit’s long-lived assets for impairment before goodwill but rather tests the disposal group, inclusive of any long-lived assets, for impairment after goodwill. In further response to the Staff’s comment, in our Form 10-K for the year ending December 31, 2025, we will revise the Assets and liabilities held for sale and discontinued operations policy within Note 2 – Significant Accounting Policies as follows: We test for impairment when we classify a disposal group as held for sale in the following order. First, we evaluate for impairment all assets outside the scope of…
Babcock & Wilcox Enterprises, Inc. · filed 2025-05-30 · 0001104659-25-054801
SEC staff comment
1. We note your disclosures related to impairment testing and the related impairments you recorded in FY 2024. Please tell us, and revise future filings to address, the following items. · More fully explain the specific facts and circumstances, including a chronology of events, that led to the $320 million in impairments you recorded for each indefinite-lived asset you impaired. · More fully discuss the key assumption you used to estimate the fair value of each impaired asset and identify and discuss the potential events and/or changes in circumstances that could reasonably be expected to negatively affect each key assumption. · Identify any forewarning disclosures you included in prior Exchange Act filings, specifically related to the impaired assets, or explain why no forewarning disclosures were provided. Securities and Exchange Commission May 23, 2025 Page 2 · We note that none of…
The company responded
During the fourth quarter of fiscal 2024, the Company recorded pre-tax, non-cash impairment charges totaling $320.0 million related to the following indefinite-lived intangible trademark assets: · Green Giant : $275 million · Victoria : $25 million · Static Guard : $15 million · McCann’s : $5 million Given the size and circumstances surrounding the Green Giant brand, we address that impairment separately below before discussing the Victoria , Static Guard and McCann’s impairments. We then conclude our response to this Comment No. 1, with our plan to enhance our future disclosures. Green Giant Trademark Impairment – Chronology and Key Events : · On a quarterly basis, our company performs impairment trigger assessments, and none were identified until the fourth quarter of 2024 when we conducted our annual impairment testing. · In the fourth quarter of 2023, our company performed our…
B&G Foods, Inc. · filed 2025-05-23 · 0001104659-25-052466
SEC staff comment
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations from Quarterly Report on Form 10-Q for the first quarter of 2024 filed on May 8, 2024 : Fluctuations in Currency Exchange Rates . . . . We also operate a manufacturing facility in Irapuato, Mexico for the manufacture of Green Giant frozen products and are as a result exposed to fluctuations in the Mexican peso. Our results of operations could be adversely impacted by changes in foreign currency exchange rates. Costs and expenses in Mexico are recognized in local foreign currency, and therefore we are exposed to potential gains or losses from the translation of those amounts into U.S. dollars for consolidation into our consolidated financial statements. For example, our results of operations from our Green Giant frozen operations in Mexico were negatively impacted during fiscal 2023 through the first…
The company responded
Our management determined that the divestiture of the Green Giant U.S. shelf-stable product line did not constitute a business under the guidance in FASB ASC 805-10-55-3A through 55-5E. As such, no goodwill was allocated to the divested assets. The product line was sold to Seneca Foods Corporation, the primary co-manufacturer responsible for producing approximately 95% of the products. The divested assets included inventory, customer lists, a license to use the Green Giant trademarks in the United States for shelf-stable vegetable products, and certain co-manufacturing agreements related to other co-manufactured products. The product line was entirely co-manufactured and the divestiture did not include any transfer of employees, proprietary manufacturing processes, manufacturing or warehousing facilities, or distribution infrastructure. In evaluating whether the divested assets…
B&G Foods, Inc. · filed 2025-05-23 · 0001104659-25-052466
SEC staff comment
3. We note that during the first quarter of FY 2024 you reorganized your reporting structure from one reportable segment to four reportable segments (i.e., Specialty, Meals, Frozen & Vegetables and Spices & Flavor Solutions), and the change in reporting structure required you to reassign assets and liabilities, including goodwill, among the four reporting units (which are the same as your reportable segments) and complete a goodwill impairment test, both prior to and subsequent to the change. Please more fully address the following: · Explain how you allocated goodwill to each reporting unit/reportable segment, including how you determined the fair values of each reporting unit/reportable segment both before and after the change.
The company responded
During the first quarter of 2024, our company reorganized our reporting structure from one reportable segment to four reportable segments: Specialty, Meals, Frozen & Vegetables and Spices & Flavor Solutions. In connection with change, we reassigned goodwill to the new reporting units based on the relative fair value of each reporting unit. To determine the relative fair values, our company engaged a third-party valuation specialist to perform a DCF analysis for each reporting unit. The DCF analysis incorporated management’s projections for net sales growth, operating margins, capital expenditures and discount rates, consistent with the guidance in FASB ASC 350-20. The change from one to four reporting units also required the allocation of other balance sheet assets and liabilities to the new reporting units. Where possible, assets and liabilities were assigned based on specific…
B&G Foods, Inc. · filed 2025-05-23 · 0001104659-25-052466
SEC staff comment
4. We note your disclosures regarding the intangible asset impairments of $320.0 million you recorded in FY 2024. Please revise future filings to provide the disclosures required by ASC 820-10-50-2, including the fair values of the assets you impaired, or explain why you do not believe additional disclosures are required. Based on the impairments, please also explain, and revise future filings to clarify, your disclosure that there was no Level 3 activity during the periods presented.
The company responded
We respectfully acknowledge the Staff’s comment. In accordance with the disclosure requirements of FASB ASC 820-10-50-2, we plan to include in our next annual report on Form 10-K the fair values of the intangible assets that we impaired during fiscal 2024 and will include similar information in future filings with respect to any future impairments. These disclosures will include the valuation techniques and significant unobservable inputs used in the fair value measurements. In addition, beginning with our most recent quarterly report on Form 10-Q/A that we filed on May 7, 2025, we added disclosure to clarify that there were no recurring Level 3 fair value measurements during the periods presented and plan to continue to do so in future filings when that is the case. For non-recurring Level 3 fair value measurements—such as those related to the impairment of goodwill and intangible…
B&G Foods, Inc. · filed 2025-05-23 · 0001104659-25-052466
SEC staff comment
5. We note you previously presented net sales by brand for each material brand pursuant to ASC 280-10-50-40. Please provide similar disclosures in future filings or explain why they are no longer required. To the extent you determine the disclosures are not required by ASC 280-10-50-40, it appears to us, given the materiality of indefinite-lived intangible assets and the impairments you recorded, similar disclosures would be required to be provided in MD&A. It appears to us that such disclosures would also be meaningful, given your disclosures that sales strategies and promotional marketing spending are centered on individual brands.
The company responded
Historically, our company operated as one operating segment. Because all of our brands had similar economic characteristics; products; production processes; types or classes of customers; distribution methods; and regulatory environment, we did not believe grouping our brands for purposes of FASB ASC 280-10-50-38 and 40 would provide meaningful information for our investors or analysts. Therefore, in response to a prior comment letter from the Staff and to comply with the guidance in FASB ASC 280-10-50-38 and 40, instead of disclosing net sales by groups of brands we began disclosing in 2014 in a footnote to our financial statements net sales by individual brand for all of our brands that exceeded a certain minimum net sales threshold (typically, 3%) and then aggregated net sales for the remaining brands. Following our recent reorganization into four reportable segments, we reassessed…
B&G Foods, Inc. · filed 2025-05-23 · 0001104659-25-052466
SEC staff comment
1. We understand from your response to prior comment one that you believe the prepayment consideration in the reverse recapitalization should be presented as an asset at fair value prior to completing the transaction because you were not able to identify alternative valuation guidance in FASB ASC 805-40 and because FASB ASC 505-10-45-2 and SAB Topic 4.E accommodate the separate presentation for receivables that are collected in cash before the financial statements are issued. However, your accounting for the prepayment consideration must be representationally faithful of the transaction to which it pertains. The transaction that you have described does not involve Rivulet Entertainment being paid cash in exchange for the shares, as suggested in your response, as the entity is instead acquired (from an accounting standpoint) by the former business of Rivulet Media in reverse…
The company responded
The Company acknowledges the staff’s comment. To that extent, the Company plans to restate its Form 10-KT filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2024 to re-classify the $27 million in issued shares from “asset purchase deposit” to a reduction in Additional paid-in capital. As discussed in the staff’s comment above, the Company does not plan to re-classify the $2.9M cash payment. As such, based on the reclassification, the restated financial statements included in the Form 10-KT/A will reflect the following updated balances as of June 30, 2024: · An asset purchase deposit balance of approximately $2.9 million and · An Additional paid-in capital balance of approximately $11.7 million Furthermore, all of the requisite disclosure in accordance with ASC 250, Accounting Changes and Error Corrections will be provided in the notes to the financial…
Rivulet Entertainment, Inc. · filed 2025-05-12 · 0001376474-25-000449
SEC staff comment
5. We note your disclosure on page 142 that revenues for each of the company’s products would be impracticable to disclose and management does not view its business by product line. Please tell us what consideration was given to disclosing revenues for significant brands, groups of similar products, or lines of businesses. In this regard, in your discussion of segment MD&A you attribute revenue fluctuations to specific brands and types of products and for goodwill impairment testing you have identified Monroe and MB Group as reporting units. Refer to ASC 280-10-50-40. Aebi Schmidt respectfully acknowledges the Staff’s comment and advises that it considers and follows the provisions of Accounting Standards Codification (“ ASC ”) 280-10-50-40, “Information about Products and Services,” when preparing its financial statements. ASC 280-10-50-40 states that a public entity shall report the…
The company responded
In response to the Staff’s comment, Aebi Schmidt has revised the disclosure on page 177 to clarify the description of key performance measures presented in or derived from Aebi Schmidt’s GAAP financial statements. These measures are not internally-derived metrics that are potentially subject to adjustment. In addition, Aebi Schmidt has removed reference to any challenges in measuring usage and engagement. Results of Operations, page 175
Aebi Schmidt Holding AG · filed 2025-05-05 · 0001140361-25-017414
SEC staff comment
1. We note that you intend to wind down manufacturing and discontinue the sale of certain legacy products offered through your Penguin Edge business and anticipate that the goodwill of the Penguin Edge reporting unit of $16.1 million may become further impaired in future periods. In future filings, please provide information for investors to assess the probability of future goodwill impairment charges related to this reporting unit. If the reporting unit is at risk of failing, you should disclose: • the percentage by which fair value exceeded carrying value at the date of the most recent test; Sidley Austin (DC) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships. Page 2 • a discussion of the degree of uncertainty associated with the assumptions; and • a description of potential events…
The company responded
We respectfully acknowledge the Staff’s comment. In the Company’s quarterly report on Form 10-Q for the quarter ended February 28, 2025, filed on April 2, 2025, the Company provided further updates regarding the expected completion timeline for the previously-announced wind down of certain aspects of the Penguin Edge reporting unit, now anticipated to be completed by approximately the end of 2025, as well as recent and expected impairments to associated goodwill, as set forth in the following disclosure on page 31: During the second quarter of 2023, we initiated a plan pursuant to which we intend to wind down manufacturing and discontinue the sale of certain legacy products offered through our Penguin Edge business by approximately the end of 2025. In connection therewith and with the preparation of the financial statements included in this Quarterly Report, we assessed goodwill…
Penguin Solutions, Inc. · filed 2025-04-30 · 0001193125-25-107591
SEC staff comment
11. You disclose other segment items include advertising and marketing expense, loss on sale of assets and impairment expense. However, the amount disclosed in the table for these items is zero. Please revise your disclosure.
The company responded
The Company acknowledges the Staff’s comment and advises the Staff that it has revised page F-37 accordingly. Notes to the Consolidated Financial Statements Oil and Natural Gas Reserve Information, page F-40
Phoenix Energy One, LLC · filed 2025-04-25 · 0001193125-25-097174
SEC staff comment
3. Please revise to quantify the recovery of certain trade receivables that had been impaired in prior years. Additionally, to the extent that the recovery was not significant, please revise to provide additional detail regarding the key facts and circumstances from your reassessment of the expected credit loss that resulted in the material reversal of the impairment loss on trade and other receivables.
The company responded
In response to the Staff’s comment, the Company has revised pages 89-90 of the Revised F-1. General
Bluemount Holdings Ltd · filed 2025-04-24 · 0002027815-25-000005
SEC staff comment
4. We note that you conducted a quantitative goodwill impairment test during the fourth quarter of fiscal 2024 due to indicators of possible impairment. Please disclose whether any of your reporting units are at risk of failing the goodwill impairment test. A reporting unit is at risk of failing the impairment test if it has a fair value that is not substantially in excess of carrying value. If no reporting units are at risk based on your most recent impairment test, disclose such information to your readers as we believe it provides them with valuable information in assessing the sensitivity of your goodwill to future impairment. Alternatively, if a reporting unit is at risk of failing the impairment test and a material impairment charge could occur, please disclose the following: • The percentage by which fair value exceeded carrying value as of the date of the most recent test; • The…
The company responded
The Company respectfully acknowledges the Staff’s comment. Based on the quantitative goodwill impairment test conducted by the Company during the fourth quarter of fiscal year 2024, the Company determined that none of the reporting units were at risk of failing the goodwill impairment test because the fair value of each reporting unit was substantially in excess of the carrying values as of the valuation date. In future filings, when a quantitative goodwill impairment test is performed, the Company confirms it will disclose if each reporting unit’s fair value is substantially in excess of the carrying values or, if the reporting unit fair value is not substantially in excess of the carrying value, then the Company will disclose the additional information in the Staff’s comment above. 17. Segment Information, page F-38
Varex Imaging Corp · filed 2025-04-24 · 0001681622-25-000054
SEC staff comment
1. Please expand your disclosure in future filings to provide information for investors to assess the probability of future goodwill impairment charges. For example, disclose whether any of your reporting units are at risk of failing the quantitative impairment test or that the fair value of each of your reporting units are substantially in excess of carrying value and are not at risk of failing. If a reporting unit is at risk of failing, you should disclose: • the percentage by which fair value exceeded carrying value at the date of the most recent test; • the amount of goodwill allocated to the reporting unit; • a more detailed description of the methods and key assumptions used and how the key assumptions were determined; • a discussion of the degree of uncertainty associated with the assumptions; and • a description of potential events and/or changes in circumstances that could…
The company responded
We respectfully acknowledge the Staff’s comment and would like to make reference to our disclosures included in the Company’s Form 10-K for the year ended December 31, 2024: • while we included a discussion of methods and key assumptions used, and the degree of uncertainty associated with such assumptions including within Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, 1 we will further emphasize any considerations that are uniquely applicable to a reporting unit at risk of failing; and • we will expand the statement in Note 10. Goodwill 2 to also include a description of more specific events and/or changes in circumstance that could reasonably be expected to negatively affect these key assumptions. In addition, we will disclose the following points more comprehensively in future filings, to provide more information for investors to further…
Mativ Holdings, Inc. · filed 2025-04-22 · 0001193125-25-089293
SEC staff comment
2. We note that you changed your reportable segments during the first quarter of 2024 as part of an organizational realignment. Please tell us whether the change in reportable segments impacted your existing reporting units prior to this change. If so, please tell us whether you performed an interim goodwill impairment test related to the existing reporting units before the change. If not, explain why not. Refer to ASC 350-20-35-3(C)(f) and 350-20-35-45. Company
The company responded
On January 24, 2024, Mativ announced a comprehensive organizational alignment initiative which included the reorganization of six business units (previously comprising the Advanced Technical Materials and Fiber-Based Solutions operating segments) into two new operating segments and two reporting units, FAM and SAS. Prior to the reorganization, the identified reporting units aligned with the Company’s six business units. As a result of the management structure changes, the FAM and SAS Group Presidents were responsible for the performance of each business and the related discrete financial information provided to the chief operating decision maker. Effective following the reorganization, we determined that the reporting units were aligned with the new FAM and SAS operating segments. The reorganization resulted in the aggregation of two legacy reporting units into FAM, and three legacy…
Mativ Holdings, Inc. · filed 2025-04-22 · 0001193125-25-089293
SEC staff comment
3. Please revise your disclosures to discuss the key facts and circumstances that resulted in the reversal of the impairment loss on trade and other receivables for the current interim period.
The company responded
In response to the Staff’s comment, the Company has revised pages 89 of the Revised F-1. Trading of timepieces, page 89
Bluemount Holdings Ltd · filed 2025-04-09 · 0002027815-25-000003
SEC staff comment
6. We note prepayments for property and equipment of $660,569 for apartments the company purchased in Tianxi Center from Chengdu Shuangfa Jundi Real Estate Co., Ltd. on June 15, 2021 which will not be received until May 2025. Please tell us why these apartments will not be received until May 2025 and your consideration of impairment of these assets in accordance with ASC 360-10.
The company responded
The Company respectfully acknowledges the Staff’s comment and hereby advises the Staff that due to the financial constraints of the developer, who serves as the construction party of this project, the project has failed to complete as scheduled. To protect the interests of homebuyers, the Chengdu government has rolled out a series of measures and provided financial assistance to ensure the project's completion. The government will be responsible for delivering the finished properties to homebuyers, with the delivery expected to be in May 2025. These assets have not been subject to impairment and the reasons are as follow: (i) The properties purchased are situated at subway entrances, offering highly convenient transportation; (ii) There are primary and secondary schools in the surrounding area, which help to categorize them as school - district properties; and (iii) Chengdu is a city…
BGM Group Ltd. · filed 2025-04-03 · 0001104659-25-031670
SEC staff comment
1 . It appears from your disclosure that you may be a shell company pursuant to Rule 405 under the Securities Act. In this regard, we note that you currently appear to have no or nominal operations. Additionally, your non-cash assets as of September 30, 2024 appear to be primarily comprised of $64,452 of property and equipment, net. However, you also note that you recognized aggregate impairment expense of $47,772 due to certain long-lived assets having a fair value less than their carrying value and recognized a gain on the sale of property and equipment during the three months ended September 30, 2024. Please explain whether you currently have more than nominal non-cash assets and provide us with a detailed legal analysis explaining why you are not a shell company or otherwise prominently disclose your shell company status on the cover page and the discuss the consequences of your…
The company responded
We appreciate your comments regarding our shell company status under Rule 405 of the Securities Act. We have carefully reviewed the issue, and below provide a detailed response to clarify why Medical Exercise Inc. does not qualify as a shell company under Rule 405 and why we believe we should not be classified as one. SCOTT D. OLSON ESQ. In SEC Release No. 33-8587, published on July 15, 2005 (the “Release”), the Securities and Exchange Commission (the “SEC”) defined a “shell company” as a company with no or nominal operations, and either no or nominal assets or assets consisting of any amount of cash and cash equivalents and nominal other assets. In adopting this definition, the Commission stated in the Release that it was trying to better describe the type of companies that were involved in certain schemes referred to in the Release. Specifically, it was focusing on companies which…
MEDICAL EXERCISE INC. · filed 2025-03-31 · 0001213900-25-026251
SEC staff comment
2. Either: a. No or nominal assets; b. Assets consisting solely of cash and cash equivalents; or c. Assets consisting of any amount of cash and cash equivalents and nominal other assets. Thus, the rule requires an analysis of, first, the operations of the company as nominal or not. If it is determined that the issuer has greater than nominal operations, no further analysis is required. However, if nominal operations are determined, we must then analyze the assets. The assets can be neither nominal nor solely consisting of cash and cash equivalent. Again, the determination of nominal is on a case by case basis. However, if an issuer whose assets consist solely of cash or cash equivalents, the issuer would be deemed a shell. It should be noted that although revenues are a good indicator of actual operations, the lack of revenues alone does not deem an issuer to have less than nominal…
The company responded
The North Palm Beach location is permanently closed. We have revised the prospectus to clarify this and remove the present tense.
MEDICAL EXERCISE INC. · filed 2025-03-31 · 0001213900-25-026251
SEC staff comment
28. On page 64, you disclose the impairment expense of $0.5 million for the nine months ended September 30, 2024 was primarily a result of lease expirations within the mineral and non-operating segment. Please expand your disclosure in your footnote and on page 64 to further explain the underlying reason(s) for the impairment expense recorded in the nine months ended September 30, 2024, similar to disclosure provided on page F-18 for the year ended December 31, 2023.
The company responded
The Company acknowledges the Staff’s comment and advises the Staff that it has revised pages 66 and F-22 accordingly. * * * * March 28, 2025 Page 11 We hope that the foregoing has been responsive to the Staff’s comments and look forward to resolving any outstanding issues as quickly as possible. Please direct any questions or comments regarding the foregoing to me by email at ross.mcaloon@lw.com or by telephone at (714) 755-8051, or to my colleague, Christopher Clark, by email at christopher.j.clark@lw.com or by telephone at (202) 637-2374. Sincerely, /s/ Ross McAloon Ross McAloon of LATHAM & WATKINS LLP cc: Adam Ferrari, Chief Executive Officer, Phoenix Energy One, LLC Curtis Allen, Chief Financial Officer, Phoenix Energy One, LLC David Wheeler, Chief Legal Officer, Phoenix Energy One, LLC Christopher J. Clark, Latham & Watkins LLP
Phoenix Energy One, LLC · filed 2025-03-28 · 0001193125-25-067215
SEC staff comment
1. We note that you included the impairment charges in the Selling, General and Administrative expenses line item of the statement of earnings. Please present the charges related to impairments in a separate line item with charges related to goodwill presented separately from other impairment charges in accordance with ASC 350-20-45-2.
The company responded
In response to the Staff’s comment, in future filings, in the cost and expenses itemization in the statement of earnings, we will present charges related to impairments in a separate line item and we will separately present charges related to goodwill, if recognized. As disclosed in Note 8 – Goodwill and Other Identifiable Intangible Assets, we recognized goodwill and intangible impairment charges of $526.5 million and $430.2 million, respectively in fiscal year 2024. We respectfully submit that the requested change would not materially change a reader’s understanding of the Company’s results of operations, as the nature and amount of the impairment charges is reflected within Note 8 and in our Critical Accounting Estimates. ​ * * * Form 8-K furnished on December 19, 2024 Exhibit 99.1
CONAGRA BRANDS INC. · filed 2025-03-26 · 0000023217-25-000006
SEC staff comment
4. We note your response to prior comment 6 explaining that while your prior management team “believed in the viability of the Orogrande project subsequent to December 31, 2022 as evidenced by the continued exploration,” you new management team “could not disregard the evidence in support of a full impairment based on its evaluation of the facts and circumstances,” although in your November 13, 2024 response to comment 12, you stated that your new management team “...still strongly believes in the scientific merits of the Orogrande Basin” while also acknowledging that “...exploration requires extensive science wells to gather the appropriate data, as well as multiple drilling and completion attempts to determine best practices.” We understand that your current Chairman was appointed on June 21, 2023 and to the position of CEO on January 18, 2024, along with the appointment of your…
The company responded
In response to the Staff’s comment, the Company proposes to amend the Annual Report by eliminating the impairment that was originally presented in the restated financial statements for the fiscal year ended December 31, 2022. The restatement of the financial statements for the year ended December 31, 2022 is subject to audit review, which is currently in process by the Company’s independent accounting firm. 3 If you have any questions or wish to discuss any matters with respect to this letter, please do not hesitate to contact me by telephone at (972) 360-1914 or by email at jjacobsen@omm.com. Respectfully submitted, /s/ O’Melveny & Myers O’Melveny & Myers LLP Jack Jacobsen, Partner cc: Gregory McCabe Chairman and Chief Executive Officer Next Bridge Hydrocarbons, Inc. 500 W. Texas Ave., Suite 890 Midland, Texas 79701 Cameron Taber, P.C. 1502 Augusta Drive, Suite 320 Houston, Texas 77057…
Next Bridge Hydrocarbons, Inc. · filed 2025-03-21 · 0001199835-25-000078
SEC staff comment
1. Please revise disclosures to explain why the legal expenses related to filing the provisional patent applications would be classified as an impairment expense as opposed to being recorded as a research and development expense. Please reference the accounting literature you relied upon in your response.
The company responded
Please see below the Company’s response to this Staff’s comment. The Company also amended its disclosures in Amendment #4. The Company has revised its disclosure to clearly state that the legal fees were initially capitalized as an intangible asset on the balance sheet but were subsequently impaired as an impairment expense in the fourth quarter of 2024. Management originally applied ASC 805-50-30-5 when recognizing the intangible asset as part of the transfer from a related party. This guidance requires that assets transferred between entities under common control be recorded at their historical carrying amounts. However, management later determined that the intangible asset did not qualify for capitalization, and the immaterial misstatement was corrected in the fourth quarter of 2024. In addressing the impairment, management referred to ASC 350-30-50-3, which outlines the disclosure…
Curanex Pharmaceuticals Inc · filed 2025-03-17 · 0001493152-25-010522
SEC staff comment
4. We note your reconciliation of total segment earnings from operations excluding corporate overhead, asset impairment charges, net gains (losses) on lease modifications, and gain on sale of assets to total earnings from operations. Please note that ASC 280-10-50-30(b) requires a reconciliation of the total of the reportable segments’ measures of profit or loss 5 to the public entity’s consolidated income before income taxes. In future filings, please revise your reconciliation to comply with this guidance.
The company responded
The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company will revise this reconciliation in accordance with ASC 280-10-50-30(b) as requested by the Staff’s comment in future filings. Comment :
GUESS INC · filed 2025-03-12 · 0000912463-25-000010
SEC staff comment
2. We note that the Diamonds Direct reporting unit estimated fair value exceeded its carrying value by 11%. Please tell us your consideration of also disclosing the carrying value of Diamonds Direct goodwill in order to provide investors with additional information that allows for an assessment of a future material impairment charge.
The company responded
We respectfully acknowledge the Staff’s comment. The carrying value of the Diamonds Direct goodwill was included in the Diamonds Direct purchase price allocation disclosed in Note 4, Acquisitions and divestitures (page 76), to the consolidated financial statements included in the Form 10-K. As the carrying value of the Diamonds Direct goodwill was available to investors in our most recently filed annual report on Form 10-K, we determined disclosure of the carrying value of the Diamonds Direct goodwill in the third quarter Form 10-Q, Critical Accounting Estimates, was not necessary. The disclosures related to the acquisition of Diamonds Direct will no longer be required in the notes to the consolidated financial statements in future filings. Therefore, to the extent similar Critical Accounting Estimates disclosures are required in future filings, we intend to include the carrying value…
SIGNET JEWELERS LTD · filed 2025-02-19 · 0000832988-25-000006
SEC staff comment
15. In your rollforward of crypto assets held for the nine months ended September 30, 2023, you disclose no impairments. However, you disclose impairments of Other crypto assets of $75,000 for the three months ended September 30, 2023. Please explain to us the circumstances of the impairment, which crypto asset was impaired, and why the impairment would not be included in your year-to-date disclosure.
The company responded
In response to Staff’s comments, the Company has updated the roll forward of crypto assets held to present the impact of impairment for the twelve months ended December 31, 2023 and 2022 and September 30, 2024. Also, please refer to our response to Staff’s Comment 18 below. As noted in the Company’s financial statements, for the year ended December 31, 2023 and 2022, impairment of crypto assets held was $440,000 and $973,000 respectively (page 75) and, as noted in the financial statements for the nine months ended September 30, 2024, the Company had impairment charges related to crypto assets held of $293,000 and $168,000 for the three months ended September 30, 2024 and 2023, respectively and $419,000 and $342,000 for the nine months ended September 30, 2024 and 2023, respectively. (page F-15) United States Securities and Exchange Commission February 11, 2025 Page 13 Notes to…
Athena Bitcoin Global · filed 2025-02-11 · 0001683168-25-000927

Showing the 60 most recent of 431.